Detailed Information

Cited 0 time in webofscience Cited 0 time in scopus
Metadata Downloads

Comparative Effectiveness of Dual Antiplatelet Therapy With Aspirin and Clopidogrel Versus Aspirin Monotherapy in Acute, Nonminor Stroke A Nationwide, Multicenter Registry-Based Study

Authors
Kim, Joon-TaePark, Man-SeokChoi, Kang-HoCho, Ki-HyunKim, Beom JoonPark, Jong-MooKang, KyusikLee, Soo JooKim, Jae GukCha, Jae-KwanKim, Dae-HyunPark, Tai HwanPark, Sang-SoonLee, Kyung BokLee, JunHong, Keun-SikCho, Yong-JinPark, Hong-KyunLee, Byung-ChulYu, Kyung-HoOh, Mi SunKim, Dong-EogRyu, Wi-SunChoi, Jay CholKwon, Jee-HyunKim, Wook-JooShin, Dong-IckSohn, Sung IlHong, Jeong-HoLee, Ji SungLee, JuneyoungBae, Hee-Joon
Issue Date
11월-2019
Publisher
LIPPINCOTT WILLIAMS & WILKINS
Keywords
aspirin; clopidogrel; myocardial infarction; propensity score; proportional hazards models
Citation
STROKE, v.50, no.11, pp.3147 - 3155
Indexed
SCIE
SCOPUS
Journal Title
STROKE
Volume
50
Number
11
Start Page
3147
End Page
3155
URI
https://scholar.korea.ac.kr/handle/2021.sw.korea/62147
DOI
10.1161/STROKEAHA.119.026044
ISSN
0039-2499
Abstract
Background and Purpose- This study aimed to compare the effectiveness of dual antiplatelet therapy with clopidogrel plus aspirin (DAPT) with that of aspirin monotherapy (AM) in patients with acute, nonminor, and noncardioembolic stroke. Methods- Using a prospective, nationwide, multicenter stroke registry database, acute (within 24 hours of onset), nonminor (baseline National Institutes of Health Stroke Scale score, 4-15), and noncardioembolic stroke patients were identified. Propensity scores using inverse probability of treatment weighting were used to adjust baseline imbalances between the DAPT and AM groups. A primary outcome measure was a composite of all types of stroke (ischemic and hemorrhagic), myocardial infarction, and all-cause mortality within 3 months of stroke onset. Results- Among the 4461 patients meeting the eligibility criteria (age, 69 +/- 13 years; men, 57.7%), 52.5% (n=2340) received AM, and 47.5% (n=2121) received DAPT. The primary outcome event was not significantly different between the DAPT group and the AM group (20.9% versus 22.6%, P=0.13). The event rates of all types of stroke were also not different between the 2 groups (19.3% versus 20.1%, P=0.35), while all-cause mortality was significantly lower in the DAPT group than in the AM group (3.4% versus 4.9%, P=0.02). In the propensity-weighted Cox proportional hazards models with robust estimation, DAPT did not reduce the risk of the primary outcome event (hazards ratio, 0.91; 95% CI, 0.79-1.04) but did reduce the risk of all-cause mortality (0.69; 0.49-0.97). There was no treatment heterogeneity among the predefined subgroups, although the potential benefits of DAPT were suggested in subpopulations of moderate-to-severe relevant arterial stenosis and relatively severe deficits (National Institutes of Health Stroke Scale score, 12-15). Conclusions- Compared to AM, clopidogrel plus aspirin did not reduce the risk of the primary outcome event during the first 3 months after a nonminor, noncardioembolic, ischemic stroke.
Files in This Item
There are no files associated with this item.
Appears in
Collections
College of Medicine > Department of Medical Science > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE